| Hang Seng Index | 23.140 HKD | -0.380 | -1.616% | 602.69M | 13.96B | 23.512 (-1.583%) HKD as at 2025/04/02 | | |
| Hang Seng China Enterprises | 85.960 HKD | -1.300 | -1.490% | 154.82M | 13.31B | 87.316 (-1.553%) HKD as at 2025/04/01 | | |
| Hang Seng TECH Index | 5.190 HKD | -0.120 | -2.260% | 674.66M | 3.52B | 5.292 (-1.931%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.510 HKD | -0.260 | -4.506% | 250.53M | 1.39B | 5.753 (-4.227%) HKD as at 2025/04/01 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 2.000 HKD | +0.088 | +4.603% | 635.51M | 1.26B | 1.925 (+3.880%) HKD as at 2025/04/01 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.712 HKD | +0.092 | +3.511% | 180.27M | 488.96M | 2.614 (+3.769%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 4.844 HKD | -0.166 | -3.313% | 43.70M | 211.77M | 5.032 (-3.738%) HKD as at 2025/04/01 | | |
| Hang Seng TECH Index | 11.110 HKD | -0.290 | -2.544% | 17.53M | 195.33M | 11.335 (-1.986%) HKD as at 2025/04/01 | | |
| Hang Seng TECH Index | 5.265 HKD | -0.125 | -2.319% | 22.63M | 119.29M | 5.368 (-1.915%) HKD as at 2025/04/01 | | |
| CSI 300 | 42.400 HKD | -0.440 | -1.027% | 1.86M | 78.99M | 42.964 (-1.312%) HKD as at 2025/04/01 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 6.175 HKD | +0.245 | +4.132% | 8.19M | 50.65M | 5.884 (+4.955%) HKD as at 2025/04/01 | | |
| Hang Seng China Enterprises | 10.560 HKD | -0.110 | -1.031% | 4.00M | 42.24M | 10.627 (-0.626%) HKD as at 2025/04/01 | | |
| London Gold Fixing Price | 2,261.000 HKD | +21.000 | +0.938% | 16.01K | 36.24M | N/A | | |
| FTSE China A50 | 12.610 HKD | -0.070 | -0.552% | 2.69M | 33.85M | 12.733 (-0.964%) HKD as at 2025/04/01 | | |
| FTSE China A50 | 13.490 HKD | -0.090 | -0.663% | 2.40M | 32.42M | 13.629 (-1.021%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 15.690 HKD | +0.170 | +1.095% | 1.11M | 17.46M | 15.452 (+1.538%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.124 HKD | -0.104 | -3.222% | 4.46M | 13.95M | 3.251 (-3.892%) HKD as at 2025/04/01 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 81.120 HKD | +6.120 | +8.160% | 155.29K | 12.45M | 75.199 (+7.874%) HKD as at 2025/04/01 | | |
| CSI Hong Kong Dividend | 33.340 HKD | -0.420 | -1.244% | 351.50K | 11.67M | 33.730 (-1.157%) HKD as at 2025/04/01 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.106 HKD | +0.068 | +1.684% | 2.23M | 9.15M | 4.030 (+1.893%) HKD as at 2025/04/01 | | |
| Hang Seng High Dividend Yield | 24.900 HKD | -0.180 | -0.718% | 328.00K | 8.17M | 24.934 (-0.136%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 19.860 HKD | -0.920 | -4.427% | 405.00K | 8.03M | 20.948 (-5.192%) HKD as at 2025/04/01 | | |
| Hang Seng Index (net total return version) | 83.260 HKD | -1.420 | -1.677% | 96.27K | 8.02M | 84.524 (-1.495%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.460 HKD | -0.140 | -3.889% | 2.07M | 7.26M | 3.614 (-4.269%) HKD as at 2025/04/01 | | |
| Solactive China Healthcare Disruption Index | 2.478 HKD | -0.032 | -1.275% | 2.82M | 6.97M | 2.507 (-1.153%) HKD as at 2025/04/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.530 HKD | -0.060 | -1.671% | 1.96M | 6.94M | 3.641 (-3.057%) HKD as at 2025/04/01 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 2.026 HKD | +0.068 | +3.473% | 3.31M | 6.70M | 1.947 (+4.041%) HKD as at 2025/04/01 | | |
| HSI ESG Enhanced Index (net total return index) | 47.120 HKD | -0.940 | -1.956% | 135.69K | 6.37M | 47.881 (-1.589%) HKD as at 2025/04/01 | | |
| Hang Seng Index | 21.700 CNY | -0.280 | -1.274% | 269.50K | 5.87M | 21.996 (-1.343%) CNY as at 2025/04/02 | | |
| FTSE US Treasury 20+ Years Index | 72.900 HKD | +1.060 | +1.476% | 80.23K | 5.83M | 71.861 (+1.447%) HKD as at 2025/04/01 | | |